Should I buy or sell Bluejay Diagnostics stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bluejay Diagnostics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BJDX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BJDX, but not buy additional shares or sell existing shares. View BJDX analyst ratings or view top-rated stocks .

How have BJDX shares performed in 2024?

Bluejay Diagnostics' stock was trading at $1.22 at the start of the year. Since then, BJDX shares have decreased by 54.6% and is now trading at $0.5533. View the best growth stocks for 2024 here .

When is Bluejay Diagnostics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024. View our BJDX earnings forecast .

How were Bluejay Diagnostics' earnings last quarter?

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) announced its earnings results on Thursday, March, 28th. The company reported ($1.78) EPS for the quarter, missing the consensus estimate of ($0.68) by $1.10.

When did Bluejay Diagnostics' stock split?

Shares of Bluejay Diagnostics reverse split before market open on Monday, July 24th 2023. The 1-20 reverse split was announced on Monday, July 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Bluejay Diagnostics IPO?

Bluejay Diagnostics (BJDX) raised $22 million in an IPO on Wednesday, November 10th 2021. The company issued 2,160,000 shares at $10.00 per share.

How do I buy shares of Bluejay Diagnostics?

Shares of BJDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:BJDX

Bluejay Diagnostics (BJDX) Stock Price, News & Analysis

→ Don’t expose yourself to stocks during the week (From DTI) (Ad)

Free BJDX Stock Alerts

$0.55

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.52
▼
$0.60
50-Day Range: $0.55
▼
$0.90
52-Week Range: $0.47
▼
$13.98

Volume: 27,489 shs
Average Volume: 47,203 shs
Market Capitalization: $1.49 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Bluejay Diagnostics alerts:

Ad DTI

Special FREE offer on stock hotsheets

These sheets tell you the exact day you should consider buying a stock… And the exact day you should consider selling it… All based on TEN YEARS of historic data and trends. For example, like January 6th through the 12th with Apple… It’s gone up every single year for the last decade. Or like May 26th through June 11th with LULU… Again - it’s gone up every single year for the last decade. Then there’s July 1st through the 21st with Walmart… What happened to WMT?

Click here and I’ll show you

About Bluejay Diagnostics Stock (NASDAQ:BJDX)

Bluejay Diagnostics, Inc., a medical diagnostic company, develops rapid test for the monitoring of disease progression in the United States. It is developing Symphony platform, a technology platform comprising Symphony analyzer that orchestrates blood processing, biomarker isolation, and immunoassay preparation using non-contact centrifugal force; and Symphony Cartridge, which includes reagents and components. The company also offers ALLEREYE diagnostic test, a point-of-care device for the diagnosis of allergic conjunctivitis. In addition, it develops IL-6 for the monitoring of disease progression in critical care; as well as hsTNT/I and NT-proBNP for the monitoring of patients acuity with chest pain. The company was incorporated in 2015 and is headquartered in Acton, Massachusetts.

BJDX Stock Price History

30 days | 90 days | 365 days | Advanced Chart

BJDX Stock News Headlines

April 9, 2024 | finance.yahoo.com

BJDX: 2023 Financial Update

March 29, 2024 | msn.com

BJDX Stock Earnings: Bluejay Diagnostics Misses EPS for Q4 2023

April 18, 2024 | DTI (Ad)

This company has increased its dividend every year for 54 years

There are three basic steps to building the Ultimate Dividend Portfolio. Step #1 is to Get The High Yields! So an index fund like the SPY, paying only 1.5% a year, isn’t going to cut it. But a company like Altria Group (MO) will.

January 2, 2024 | finance.yahoo.com

Bluejay Diagnostics Announces Closing of $3.5 Million Public Offering

December 28, 2023 | marketwatch.com

Bluejay Diagnostics Shares Slide Premarket After Stock Offering

December 28, 2023 | msn.com

Why BlueJay Diagnostics Stock Is Falling

December 28, 2023 | markets.businessinsider.com

Bluejay Diagnostics Prices Offering Of 2.692 Mln Shares At $1.30/shr

December 28, 2023 | msn.com

BJDX: SYMON Says: Start the Trial! - MSN

April 18, 2024 | Darwin (Ad)

2024's Must-Have Guide: Master Crypto Investment Today

The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

December 28, 2023 | finance.yahoo.com

BJDX: SYMON Says: Start the Trial!

December 28, 2023 | finance.yahoo.com

Bluejay Diagnostics Announces Pricing of $3.5 Million Public Offering

November 21, 2023 | msn.com

Bluejay Diagnostics files to sell common stocks, warrants

November 10, 2023 | msn.com

Bluejay Diagnostics GAAP EPS of -$2.08

November 9, 2023 | finance.yahoo.com

Bluejay Diagnostics, Inc. Reports Third Quarter 2023 Financial Results

November 8, 2023 | finance.yahoo.com

BJDX: Toray License Renegotiation

October 21, 2023 | health.usnews.com

Blue adVantage Premier (PPO)

October 21, 2023 | health.usnews.com

True Blue Special Needs Plan (HMO D-SNP)

September 20, 2023 | benzinga.com

What's Going On With Bluejay Diagnostics Stock Today?

August 28, 2023 | finance.yahoo.com

BJDX: FDA Meeting Confirms Pathway

August 16, 2023 | finanznachrichten.de

Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

August 16, 2023 | finance.yahoo.com

Bluejay Diagnostics Announces Clinical Update and Reports Second Quarter 2023 Financial Results

August 11, 2023 | finance.yahoo.com

Bluejay Diagnostics Regains Compliance with Nasdaq Minimum Bid Price Requirement

August 3, 2023 | msn.com

Dawson James Downgrades Bluejay Diagnostics (BJDX)

August 3, 2023 | msn.com

Bluejay Diagnostics (BJDX) Price Target Increased by 1900.00% to 61.20

July 28, 2023 | benzinga.com

What's Going On With BlueJay Diagnostics Stock?

July 24, 2023 | marketwatch.com

Bluejay Diagnostics Shares Rise 82% After Reverse Stock Split

July 24, 2023 | finance.yahoo.com

Will Bluejay Diagnostics (NASDAQ:BJDX) Spend Its Cash Wisely?

See More Headlines

Receive BJDX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Bluejay Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/28/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/08/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Surgical & medical instruments
Sub-Industry: N/A
Current Symbol: NASDAQ:BJDX
CUSIP: N/A
CIK: 1704287
Web: www.bluejaydx.com
Phone: 844-327-7078
Fax: N/A
Employees: 10
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($9.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-9,950,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -168.38%
Return on Assets: -122.58%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 1.82
Quick Ratio: 1.82

Sales & Book Value

Annual Sales: $250,000.00
Price / Sales: 5.95
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $2.34 per share
Price / Book: 0.24

Miscellaneous

Outstanding Shares: 2,688,000
Free Float: 1,425,000
Market Cap: $1.49 million
Optionable: Not Optionable
Beta: 0.85

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

Mr. Indranil Dey (Age 60)
Principal Financial, Accounting & Executive Officer, President, CEO and Director
Comp: $413.16k
Dr. Jason Cook (Age 41)
Chief Technology Officer
Comp: $278.42k
Mr. Les DeLuca
Vice President of Operations
Eryn Graham
Marketing Manager
Mr. Kevin Vance (Age 66)
Chief Commercial Officer
Mark W. Feinberg
Chief Medical Advisor
Dr. Mark W. Feinberg M.D.
Chief Medical Advisor
Ryan McSeveney
Corporate Controller

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

BJDX Stock Analysis - Frequently Asked Questions

Should I buy or sell Bluejay Diagnostics stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Bluejay Diagnostics in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" BJDX shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in BJDX, but not buy additional shares or sell existing shares.
View BJDX analyst ratings or view top-rated stocks.
How have BJDX shares performed in 2024?: Bluejay Diagnostics' stock was trading at $1.22 at the start of the year. Since then, BJDX shares have decreased by 54.6% and is now trading at $0.5533.
View the best growth stocks for 2024 here.
When is Bluejay Diagnostics' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our BJDX earnings forecast.
How were Bluejay Diagnostics' earnings last quarter?: Bluejay Diagnostics, Inc. (NASDAQ:BJDX) announced its earnings results on Thursday, March, 28th. The company reported ($1.78) EPS for the quarter, missing the consensus estimate of ($0.68) by $1.10.

When did Bluejay Diagnostics' stock split?: Shares of Bluejay Diagnostics reverse split before market open on Monday, July 24th 2023. The 1-20 reverse split was announced on Monday, July 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, July 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
When did Bluejay Diagnostics IPO?: Bluejay Diagnostics (BJDX) raised $22 million in an IPO on Wednesday, November 10th 2021. The company issued 2,160,000 shares at $10.00 per share.
How do I buy shares of Bluejay Diagnostics?: Shares of BJDX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:BJDX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial